42 related articles for article (PubMed ID: 12807745)
1. Rat mammary carcinogenesis induced by in situ expression of constitutive Raf kinase activity is prevented by tethering Raf to the plasma membrane.
McFarlin DR; Gould MN
Carcinogenesis; 2003 Jun; 24(6):1149-53. PubMed ID: 12807745
[TBL] [Abstract][Full Text] [Related]
2. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
4. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R
Cancer Res; 2003 Jul; 63(14):4232-8. PubMed ID: 12874031
[TBL] [Abstract][Full Text] [Related]
6. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
[TBL] [Abstract][Full Text] [Related]
7. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
[TBL] [Abstract][Full Text] [Related]
8. Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways.
Chang MS; Chen BC; Yu MT; Sheu JR; Chen TF; Lin CH
Cell Signal; 2005 Mar; 17(3):299-310. PubMed ID: 15567061
[TBL] [Abstract][Full Text] [Related]
9. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland.
Thompson TA; Kim K; Gould MN
Cancer Res; 1998 Nov; 58(22):5097-104. PubMed ID: 9823318
[TBL] [Abstract][Full Text] [Related]
10. Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas.
McFarlin DR; Lindstrom MJ; Gould MN
Carcinogenesis; 2003 Jan; 24(1):99-105. PubMed ID: 12538354
[TBL] [Abstract][Full Text] [Related]
11. Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity.
Grewal T; Evans R; Rentero C; Tebar F; Cubells L; de Diego I; Kirchhoff MF; Hughes WE; Heeren J; Rye KA; Rinninger F; Daly RJ; Pol A; Enrich C
Oncogene; 2005 Sep; 24(38):5809-20. PubMed ID: 15940262
[TBL] [Abstract][Full Text] [Related]
12. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
13. Raf pathway inhibitors in oncology.
Bollag G; Freeman S; Lyons JF; Post LE
Curr Opin Investig Drugs; 2003 Dec; 4(12):1436-41. PubMed ID: 14763129
[TBL] [Abstract][Full Text] [Related]
14. Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040 strongly reduces growth and improves lung structure.
Kramer BW; Götz R; Rapp UR
BMC Cancer; 2004 Jun; 4():24. PubMed ID: 15171791
[TBL] [Abstract][Full Text] [Related]
15. Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis.
Pap T; Nawrath M; Heinrich J; Bosse M; Baier A; Hummel KM; Petrow P; Kuchen S; Michel BA; Gay RE; Müller-Ladner U; Moelling K; Gay S
Arthritis Rheum; 2004 Sep; 50(9):2794-802. PubMed ID: 15457447
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.
Maschler S; Grunert S; Danielopol A; Beug H; Wirl G
Oncogene; 2004 Apr; 23(20):3622-33. PubMed ID: 15116096
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.
Xuan W; Li YJ; Liu G; Ben-David Y; Archer MC
Mol Cancer Res; 2009 Mar; 7(3):433-42. PubMed ID: 19258414
[TBL] [Abstract][Full Text] [Related]
18. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
19. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
20. BAG-1 haplo-insufficiency impairs lung tumorigenesis.
Götz R; Kramer BW; Camarero G; Rapp UR
BMC Cancer; 2004 Nov; 4():85. PubMed ID: 15560850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
